NCT06369207

Brief Summary

Chronic venous insufficiency (CVI) is one of the most common medical problems in adults that occurs secondary to the reflux of blood through incompetent valves of lower extremity veins. The most common involved valve is the valve located at the saphenofemoral junction. Although the pathway of reflux transmission is not the same in all patients, the removal or ablation of the greater saphenous vein (GSV) is considered a standard treatment in these patients. However, in patients whose reflux is transmitted to branches other than GSV, this treatment leads to the unnecessary destruction of a competent segment of GSV in addition to remaining at least some segments of incompetent veins. So, in this study, the investigators intend to investigate the different pathways of reflux transmission in chronic venous insufficiency patients who are candidates for GSV ablation/stripping because of saphenofemoral junction insufficiency. This cross-sectional study will be conducted with a descriptive-analytical approach. .

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 12, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 15, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 12, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 16, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2024

Completed
Last Updated

September 20, 2024

Status Verified

September 1, 2024

Enrollment Period

5 months

First QC Date

April 12, 2024

Last Update Submit

September 18, 2024

Conditions

Keywords

venous insufficiencyrefluxultrasonographic mappingsaphenofemoral junction

Outcome Measures

Primary Outcomes (1)

  • Determination of reflux transmission pathways in CVI patients with SFJ incompetency

    Determining the transmission pathways of reflux in patients with chronic venous insufficiency secondary to saphenofemoral reflux referring to vascular surgery clinics in Golestan province from 2022 to 2023

    one year

Secondary Outcomes (3)

  • Anatomic variations of GSV in CVI patients with SFJ incompetency

    one year

  • Prevalence of reflux along GSV main trunk in CVI patients with SFJ incompetency

    one year

  • Prevalence of reflux along accessory saphenous veins in CVI patients with SFJ incompetency

    one year

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All included participants are visited the day before surgery and venous mapping is performed for the patient by the vascular surgeon. The reflux pathway is marked on the skin and information regarding the anatomic characteristics of the reflux are recorded.

You may qualify if:

  • Age\>18.
  • Chronic Venous Insufficiency with a clinical grade of 3 (varicosity) or more.
  • Documentation of saphenofemoral junction insufficiency on Doppler ultrasound performed by a radiologist.
  • Patient consent.

You may not qualify if:

  • \- History of DVT

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pezhman Kharazm, MD

Gorgan, Golestan Province, 4917956808, Iran

Location

MeSH Terms

Conditions

Venous InsufficiencyGastroesophageal Reflux

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesEsophageal Motility DisordersDeglutition DisordersEsophageal DiseasesGastrointestinal DiseasesDigestive System Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Vascular Surgeon

Study Record Dates

First Submitted

April 12, 2024

First Posted

April 16, 2024

Study Start

September 12, 2023

Primary Completion

February 15, 2024

Study Completion

September 15, 2024

Last Updated

September 20, 2024

Record last verified: 2024-09

Locations